Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent manner

Chelerythrine is still marketed as a specific PKC inhibitor and extensively used in signal transduction studies. We believe that the described off-target effects should preclude its use as a PKC inhibitor in future works.